Gut bacteria may worsen liver disease – new study investigates
NCT ID NCT02400216
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how bacteria from the gut might travel to the liver and make liver disease worse in people with hepatitis C. Thirty adults with stable liver disease took part. Researchers used blood tests, MRI scans, and liver tissue samples to measure bacterial movement and liver function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dual cholate
- What this could lead to
- If successful, this could help doctors better understand how gut bacteria affect liver disease in people with hepatitis C.
- What could go wrong
- This is a small, observational study with only 30 participants. It is not testing a treatment, so it will not directly improve health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can everyday drugs shield the liver from Cirrhosis's worst threats?
- Could a yellow tinge predict dangerous hospital infections?
- Muscle quality on MRI may foretell liver transplant success
- Melatonin may ease sleep and brain fog in liver disease — a trial puts it to the test
- Heart scans could uncover silent damage in liver patients awaiting transplant
- Could the Body's largest vein replace a Hard-to-Reach one for liver pressure checks?